MENU
CLRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cellectar Biosciences (CLRB) Earnings Date & Reports
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CLRB is expected to report earnings to fall 54.89% to -60 cents per share on August 19
Q2'26
Est.
$-0.60
Q1'26
Missed
by $1.13
Q4'25
Missed
by $1.15
Q3'25
Missed
by $1.27
Q2'25
Missed
by $3.26
The last earnings report on May 14 showed earnings per share of -133 cents, missing the estimate of -20 cents. With 35.26K shares outstanding, the current market capitalization sits at 20.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
11
Web
https://www.cellectar.com